Cambrex Corporation · East Rutherford, NJ United States (NYSE: CBM)
| 1 Meadowlands Plaza | Phone: 201-804-3000 |
| East Rutherford, NJ | Fax: 201-804-9852 |
| 07073 | |
| United States | 
Map This Company |
Cambrex Corporation Rankings
| S&P 600 |
More Companies in These Related Industries: Pharmaceutical Preparation Mfg, Biologics Mfg, Bleaching Agents MfgCompany Description
Cambrex focuses on health. The company develops products for the human health care market that include active pharmaceutical ingredients and intermediates for over-the-counter and prescription drugs. It also makes intermediates used in cosmetics and food additives. Cambrex focuses on developing drug delivery technologies and the manufacture of high-potency compounds and controlled substances. It maintains manufacturing and R&D facilities in Italy, India, Sweden, and the US. Expanding its biocatalysis platform (which uses natural catalysts to transform organic compounds), Cambrex acquired Germany-based IEP GmbHa, an industrial biocatalysis company, in 2010.
Cambrex Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NYSE: CBM Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 833 |
Executives
53 executives listed for Cambrex Corporation's East Rutherford, NJ location.
| Chairman | John Miller | |
|---|---|---|
| President, CEO, and Director | Steven Klosk | |
| VP and CFO | Gregory Sargen |